Cleared Traditional

K870945 - RABBIT PLASMA FIBRINOGEN SUPPLEMENT SR 122

K870945 is the FDA 510(k) clearance for RABBIT PLASMA FIBRINOGEN SUPPLEMENT SR 122 by Oxoid U.S.A., Inc.. It is a Class 1 Microbiology device (product code JTL) cleared through the Traditional 510(k) pathway after a 93-day FDA review.

K870945 · Oxoid U.S.A., Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1987
Decision
93d
Days
Class 1
Risk

K870945 is an FDA 510(k) clearance for the RABBIT PLASMA FIBRINOGEN SUPPLEMENT SR 122. Classified as Plasma, Coagulase, Human, Horse And Rabbit (product code JTL), Class I - General Controls.

Submitted by Oxoid U.S.A., Inc. (Columbia, US). The FDA issued a Cleared decision on June 10, 1987 after a review of 93 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.2160 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Oxoid U.S.A., Inc. devices

Submission Details

510(k) Number K870945 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 09, 1987
Decision Date June 10, 1987
Days to Decision 93 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
9d faster than avg
Panel avg: 102d · This submission: 93d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JTL Plasma, Coagulase, Human, Horse And Rabbit
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.2160
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JTL Plasma, Coagulase, Human, Horse And Rabbit

All 7
Devices cleared under the same product code (JTL) and FDA review panel - the closest regulatory comparables to K870945.
DRYSLIDE COAGULASE
K950706 · Difco Laboratories, Inc. · May 1995
HEMASTAPH
K840553 · Remel Co. · Apr 1984
API STAPHASE III
K833988 · Analytical Products, Inc. · Dec 1983
COAGULASE PLASMA, HORSE & RABBIT EDTA
K833858 · Otisville Biotech, Inc. · Dec 1983
RABBIT COAGULASE PLASMA
K812602 · Dutchland Laboratories, Inc. · Sep 1981
STAPHASE*
K811982 · Analytical Products, Inc. · Jul 1981